-
Italy researchers claim vaccine neutralises coronavirus in human cells
pharmaceutical-technology
May 06, 2020
Scientists at Lazzaro Spallanzani National Institute for Infectious Diseases in Italy have claimed that a vaccine candidate could neutralise coronavirus within human cells.
-
Scientists to culture novel coronavirus in human lung epithelial cell
expresspharma
May 06, 2020
It will enable in vitro testing of potential drugs and vaccines against COVID-19.
-
Gilead’s anti-viral remdesivir may be found effective against coronavirus
expresspharma
May 06, 2020
The company is in discussions with some of the world’s leading chemical and pharmaceutical manufacturing companies about their ability, under voluntary licenses, to produce remdesivir for Europe, Asia and the developing world through at least 2022.
-
MedPharm Expands Testing Models to Target Coronavirus
contractpharma
April 29, 2020
Helps accelerate treatment development prior to clinical trials.
-
Oral polio vaccine can be effective against coronavirus: HIV co-discoverer
expresspharma
April 27, 2020
The vaccine has been documented to provide protection against a number of viral and bacterial infections other than poliomyelitis, including flu, said Dr Robert Gallo.
-
Trial of Gilead’s potential coronavirus treatment running ahead of schedule – researcher
expresspharma
April 26, 2020
Preliminary findings from the randomized trial of the antiviral drug remdesivir, begun in February by the National Institute of Allergy and Infectious Diseases (NIAID), could come even sooner, lead researcher Dr Andre Kalil told Reuters.
-
FDA Update: Serological Test Validation and Education Efforts
americanpharmaceuticalreview
April 24, 2020
Every step we have taken as part of our approach to COVID-19 testing has been a careful balancing of risks and benefits in order to meet the urgent public health needs as we combat this new pathogen.
-
Research focus should remain on high quality studies during COVID-19 pandemic, say scientists
europeanpharmaceuticalreview
April 24, 2020
Scientists have argued in a commentary piece that global crises are no excuse for lowering scientific standards in research.
-
Gilead disputes report that its drug flopped in leaked coronavirus trial
expresspharma
April 24, 2020
In the Chinese trial remdesivir, given by intravenous infusion, failed to improve patients’ condition or reduce the pathogen’s presence in the bloodstream, according to draft documents published accidentally by the World Health Organization (WHO).
-
J&J strikes deal with Emergent BioSolutions on coronavirus vaccine manufacturing
expresspharma
April 24, 2020
Under the deal, valued at about $135 million, Emergent said it would provide drug substance manufacturing services and was reserving large-scale manufacturing capacity.